Information on new prescription diet pills
Lorcaserin is a possible future diet pill being developed by Arena Pharmaceuticals out of California. And unlike Qnexa and Contrave that are combination drugs, Lorcaserin finds itself as a single new drug being experimented with. Chemically, Lorcaserin has a similar make up to that dreaded drug Fenfluramine, which was gained its reputation from the now infamous Phen-Fen. But unlike Phen-Fen, Lorcaserin has not been shown to cause any heart value problems. In fact it looks as if Lorcaserin has shown the least of the side effects compared to Qnexa and Contrave.
However, with its lower side effects also comes a less potent drug for weight loss. This however may prove to be what saves Lorcaserin. Some of the past diet pills have been pulled in certain countries, Rimonabant and Sibutramine for example are no longer available in most European Countries due to side effects and Rimonabant never made it past the FDA due to side effects. If the FDA is strict on the side effects issue, Lorcaserin may be able to squeak past the regulators where some of the others may be rejected. Inversely, it may be viewed by the FDA that Lorcaserin is not effective enough to be passed, even though it meets their requirements of at least one third of the patients lose 5% of their body mass. Some possible side effects associated with Lorcaserin are headache, dizziness, dry mouth, fatigue, nausea but overall tolerated fairly well.
Another potential saving grace for Lorcaserin is that in studies released, it was shown to have a low chance of abuse potential. It is very unlikely that people would be obtaining this medication to feel elated. Other diet drugs may not be able to make the same claim such as Phentermine. This also may encourage some doctors to prescribe such a medication knowing there is a low chance that any of their patients will then become addicted to it and be trying to obtain it through illegal means.
It was on December 22nd 2009 that Arena Pharmaceuticals submitted Lorcaserin to the Federal Drug and Food Administration to review it in hopes of approval. It will probably be around October 2010 when anyone hears back about its approval or not. Our thoughts is that while Lorcaserin may not be as effective as some of the other diet medications out there, the low side effects and low chance of abuse make it an excellent medication for those needing help. It is possible that if Qnexa or Contrave are approved, that some doctors may try obese patients on one of those and if the side effects are too great for one to bear or other interactions happen, than Lorcaserin maybe used. This is just mere speculation however and holds no grounds for any debate. The argument behind this statement originates from a doctor hinting at the prospect that Lorcaserin may not be strong enough in his opinion and that the others seem more likely for weight loss success. But many physicians would rather start with Lorcaserin and progress to other treatments if deemed necessary.
While some people object to a medication for obesity, others applaud such a development. For people who have suffered with obesity, only they truly understand the difficulties in trying to lose weight. There are also those with ailments making weight loss even more difficult. People suffering from obesity who are disabled for example don't always have the same opportunities to burn calories. Other diseases such as Cushing's disease can cause ones body to produce high levels of adrenocorticotropic hormone thus making weight loss near impossible.